Article

B+L, Walgreens to collaborate on eye health program

Bausch + Lomb (B+L) and Walgreens will collaborate on SightSense, a new online and in-store patient education program to heighten eye health awareness.

Rochester, NY and Deerfield, IL-Bausch + Lomb (B+L) and Walgreens will collaborate on SightSense, a new online and in-store patient education program to heighten eye health awareness and encourage consumers to take proactive steps to protect and preserve their sight.

“We know that more than 80% of visual impairment is preventable, which makes it that much more important to elevate eye health awareness among consumers,” said Calvin Roberts, MD, B+L executive vice president and chief medical officer. “Through the SightSense program we have an opportunity to do just that, and ultimately help people preserve and protect their most treasured sense, as well as improve their overall health.”

The SightSense program features a special eye health section on Walgreens.com that provides tools, information, and resources to help consumers become informed and proactive in their eye health. SightSense in-store events will be held in approximately 10 cities across the country in 2013.

“By raising awareness of eye health as an integral part of a consumer's overall preventive care plan, we further enrich the wellness experience available to and accessible for our customers, ” said Robert London, MD, Walgreens national medical director.

Through both the online and in-store components of the SightSense program, consumers will be encouraged to get regular eye exams from their local eye care professionals, a key step to maintaining healthy eyes and preventing other health-related issues.

B+L and Walgreens will work together to build greater awareness about issues like these by providing consumers with the educational resources they need to increase their knowledge.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
© 2025 MJH Life Sciences

All rights reserved.